Nuclear Medicine & Radiation Therapy

Used for the first time in 1941 in the United States by Hertz and Roberts for the treatment of hyperthyroidism in Grave's Disease, radioactive therapy (RAI) has been able to gain its place within the already existing therapeutic arsenal by being efficient, easy to use and minimally invasive. Our work is a retrospective study of 71 patients collected at the Department of nuclear medicine of the University Hospital Hassan II of Fez, over a period of 6 years from 2013 to 2019. The purpose of this study is to determine the place of radioiodine therapy in the treatment of Graves' disease in our context and to evaluate its results.